Navigation Links
UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation
Date:6/18/2013

University Hospitals Case Medical Center clinical researchers have launched an innovative clinical trial, unique in its design, which will evaluate the ability of a patient's own stem cells to prevent leg amputations in end stage peripheral arterial disease (PAD).

Led by Vik Kashyap, MD, Division Chief, Vascular Surgery at University Hospitals Case Medical Center's Harrington Heart & Vascular Institute and Professor of Surgery at Case Western Reserve University School of Medicine, the clinical trial is designed to improve blood flow in legs with blocked arteries by attempting to treat diseased blood vessels. Peripheral arterial disease (PAD) is a common yet serious disease that occurs when extra cholesterol and fat circulating in the blood collects on the walls of the arteries that supply blood to the limbs.

Due to the location and extent of the blockages in certain individuals, standard treatments such as surgical bypass (insertion of a vein or synthetic graft to redirect blood flow around the blockage) and angioplasty (insertion of a balloon through the artery to open the blockage) will not improve blood flow to the leg, and amputation is the only alternative.

For patients with critical limb ischemia (CLI) revascularization procedures such as surgical bypass or percutaneous angioplasty/stenting are currently the only option to restore perfusion and maintain limb viability.

For CLI patients who are non-candidates for revascularization, amputation is often needed. It is estimated that over 160,000 amputations are performed in the United States each year.

The number of CLI patients who will not be candidates for revascularization continues to rise as the population ages and the incidence of diabetes and other vascular risk factors increase. For CLI patients who are considered unreconstructable, the amputation and mortality rates at six months approach 40% and 20%, respectively. Furthermore, nearly 30% of patients
'/>"/>

Contact: Mike Ferrari
mike.ferrari@uhhospitals.org
216-844-7239
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Physician Groups Call for Fewer Medical Tests
2. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
3. CAM therapy combined with conventional medical care may improve treatment of lower back pain
4. Image share project gives patients and physicians anytime, anywhere access to medical images
5. Researchers determine vitamin D blood level for reducing major medical risks in older adults
6. Biomedical researchers receive Hartwell Foundation awards
7. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
8. Fitness in Middle Age Lowers Medical Costs Later: Study
9. Ben-Gurion U. and Cincinnati Childrens Hospital to develop pediatric-specific medical technologies
10. Gene Tests May Not Drive Patients to More Medical Care
11. University studies and career expectations of medical students
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 28, 2015 More than 300 locations ... raise money to help the Muscular Dystrophy Association save ... and related life-threatening diseases that limit muscle strength and ... program. , From June 1 to June 30, sweetFrog ... the opportunity to help send local children affected by ...
(Date:5/28/2015)... 2015 ZH Healthcare (ZH), a leading ... is releasing BlueEHS, the Electronic Health Solution, on the ... the benefit of all AWS users worldwide. , ... of its kind, Freemium, SaaS, Electronic Health Solution (EHS). ... with an integrated practice management system (PMS), e-Rx, lab ...
(Date:5/28/2015)... May 28, 2015 CompanionDx ... company, announces that it will present their integrated ... testing at the annual American Society of Clinical ... sequencing evaluates the DNA in a patient’s tumor ... analyzed for key changes or somatic mutations. Pharmacogenomics ...
(Date:5/28/2015)... 28, 2015 Sexual Health Innovations, ... advances sexual health and wellbeing in the United ... San Francisco (USF) will be the first institution ... recording and reporting system. , Callisto is ... confidential reporting experience for college sexual assault survivors, ...
(Date:5/28/2015)... 28, 2015 Cancer survivors who participated ... in physical activity, fitness and quality of life, according ... Cancer Center and Jennifer Ligibel, MD, senior physician in ... Farber Cancer Institute. The findings will be presented at ... Annual Meeting in Chicago. , The ...
Breaking Medicine News(10 mins):Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 2Health News:BlueEHS, the Electronic Health Solution, now available on Amazon AWS Market place 3Health News:CompanionDx® Launches Integrated Genomic Solution at ASCO Meeting 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4
... ... vice president of the company,s Hoosier Region, with one of its two Heartland Division President,s ... ... honored John Conlon, vice president of the company,s Hoosier Region, with one of its two ...
... , ... Capabilities and Added Experience Highlight the New Pediatric Speech Therapy Partnership , ... Atlanta, GA (PRWEB) September 22, ... with school systems across the U.S., is pleased to announce that Travis Consulting, LLC ...
... , Report presents findings by ... , , NEW YORK, Sept. 22 ... in 15 years, and at a time of heightened economic insecurity, new ... trending downward in a number of important areas. The State of ...
... , TAMPA, Fla., Sept. 16 ... announced today that the US Food and Drug Administration (FDA) ... gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ... this indication in April 2007. , , ...
... today [Thursday] estimates nearly 45,000 annual deaths are associated with ... a half times higher than an estimate from the Institute ... Insurance and Mortality in U.S. Adults," appears in today,s [Thursday,s] ... . The Harvard-based researchers found that uninsured, working-age Americans ...
... study in the world of treatments for post menopausal, ... continue to take exemestane or tamoxifen do significantly better ... drug (or tamoxifen followed exemestane) but then stop. ... central data office for TEAM (tamoxifen exemestane adjuvant multinational) ...
Cached Medicine News:Health News:Conlon Wins Life Care's Heartland Division President's Award 2Health News:Cobb Pediatric Therapy Services Joins Forces with Travis Consulting, LLC to Offer Expanded Services Across the U.S. 2Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 2Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 3Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 4Health News:New Families and Work Institute Study Reveals Declines in the Health of American Workforce 5Health News:Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis 2Health News:Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis 3Health News:Sirion Therapeutics Announces FDA Approval of Zirgan(TM) (Ganciclovir Ophthalmic Gel) 0.15% for Herpetic Keratitis 4Health News:45,000 excess deaths annually linked to lack of health insurance: Harvard study 2Health News:Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance 2Health News:Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance 3Health News:Study of adjuvant endocrine treatment for breast cancer reveals cost of noncompliance 4
(Date:5/28/2015)... , May 28, 2015 ... the concerned market with analysis and forecast of revenue. ... and is estimated to reach $1,177.8 million by 2019, ... Browse through the TOC of Mannequin-Based Simulation ... and segments, with help of various tables and figures. ...
(Date:5/28/2015)... Colo. , May 28, 2015  Array BioPharma ... encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the ... which will be held May 29 – June 2, ... three products are currently advancing in a total of ... from both the NEMO (binimetinib monotherapy in NRAS mutant ...
(Date:5/28/2015)... ALBANY, N.Y. , May 28, 2015 /PRNewswire/ ... "503B Outsourcing Facility" under section 503B of the ... for this title, the company is subject to ... oversight, producing bulk medications according to the highest ... 21 CFR Part 211. To continuously comply with ...
Breaking Medicine Technology:Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3
... announces the release of VB E ... serialization and traceability regulations for pharmaceutical, biologics, medical device and ... 4.0 for Life Sciences adds support for GS1 standards, ... Verify Brand™ has also gone beyond compliance requirements ...
...   Seminars: February 14-15, 2012 ,Exhibition: February ... largest packaging tradeshow, announced the launch of two new ... 14-16, 2012. The seminars focus on sustainability and automation ... impacting all sectors of the packaging industry. ...
Cached Medicine Technology:Verify Brand™ Announces the Release of VB Enterprise 4.0 for Life Sciences 2Verify Brand™ Announces the Release of VB Enterprise 4.0 for Life Sciences 3WestPack Launches New Sustainability and Automation and Cost Control Seminars 2
TOX/See is a 1-step, hand-held, point-of-care device for the qualitative detection of drug or drug metabolites in human urine....
Compact, bench-top analyser with minimal water volume requirements and easy waste management....
Compact benchtop clinical chemistry system...
... offers easy operation, maintenance, and training. Whether you ... to the powerful VITROS 5,1 FS, the VITROS ... right the first time. Its that simple. , ... and easy-to-use. The VITROS 350 comes complete with ...
Medicine Products: